Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS
B06AX Other hematological agents
B06AX03 Voxelotor
D11330 Voxelotor (USAN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Voxelotor
D11330 Voxelotor (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02919 CYP2B6 substrate
D11330 Voxelotor
DG01642 CYP2C9 substrate
D11330 Voxelotor
DG01639 CYP2C19 substrate
D11330 Voxelotor
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11330 Voxelotor
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11330
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11330
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11330